Compare ResMed Inc. (RMD) vs Super Group (SGHC) Limited Ordinary Shares (SGHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Super Group (SGHC) Limited Ordinary Shares — how do they compare? ResMed Inc. trades at $230.96 (market cap $31.89B), while Super Group (SGHC) Limited Ordinary Shares trades at $11.33 (market cap $5.86B). The key difference: ResMed Inc. is far larger — about 5.4× Super Group (SGHC) Limited Ordinary Shares's market cap, and Super Group (SGHC) Limited Ordinary Shares pays the higher dividend (1.73%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Super Group (SGHC) Limited Ordinary Shares for 0 Days on average.
| RMD | SGHC | |
|---|---|---|
Market Cap | $31.89B | $5.86B |
Volume | 618,314 | 1,905,788 |
Sector | Health | Consumer Cyclical |
52-Week High | $277.88 | $15.59 |
52-Week Low | $182.82 | $8.52 |
Typical Hold Time | 51 Days | 0 Days |
Enterprise Value | $31.24B | $5.41B |
Dividend Yield | 1.16% | 1.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $230.91, up 2.18% today, with a bullish technical signal and strong fundamentals. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $2.68. Revenue grew to $5.15B in 2025, with a net income margin of 26.94%. Analyst consensus is a buy, with a $242.70 price target. Recent news highlights EPS growth targets of 12%-14% and participation in investor conferences.
Outlook is positive due to robust earnings growth and market share gains, but risks include competitive pressures and regulatory investigations. The stock offers upside to the consensus target, supported by institutional buying and solid cash flow generation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Super Group (SGHC) Limited Ordinary Shares
Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.
Read more on SGHC →
